Not applicableLooking for participantsNCT05655260What this trial is testingPErsonalized TReatment for Endometrial CarcinomaWho this might be right forEndometrial Adenocarcinoma University of Helsinki 300
Very early researchTemporarily pausedNCT04494113What this trial is testingTesting the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of HysterectomyWho this might be right forEndometrial Serous Adenocarcinoma National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Ended earlyNCT01164150What this trial is testingProspective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer. ICORG 09-06Who this might be right forEndometrial CancerGastrointestinal ComplicationsRadiation Toxicity+1 more Cancer Trials Ireland 92
Not applicableStudy completedNCT04458597What this trial is testingStereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus.Who this might be right forEndometrioid AdenocarcinomaSerous CarcinomaClear Cell Carcinoma+2 more London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 23
Testing effectiveness (Phase 2)Study completedNCT01642082What this trial is testingDalantercept in Treating Patients With Recurrent or Persistent Endometrial CancerWho this might be right forEndometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mixed Adenocarcinoma+6 more Gynecologic Oncology Group 28
Testing effectiveness (Phase 2)Looking for participantsNCT04008797What this trial is testingE7386 in Combination With Other Anticancer Drug(s) in Participants With Solid TumorWho this might be right forEndometrial NeoplasmsNeoplasmsCarcinoma, Hepatocellular+2 more Eisai Inc. 301
Early research (Phase 1)Study completedNCT00005840What this trial is testingCombination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial CancerWho this might be right forEndometrial Clear Cell AdenocarcinomaEndometrial Serous AdenocarcinomaStage III Uterine Corpus Cancer+1 more Gynecologic Oncology Group 35
Early research (Phase 1)WithdrawnNCT04611139What this trial is testingPilot Trial of SP-2577 Plus Pembrolizumab in Select Gynecologic CancersWho this might be right forSCCOHTOvarian Clear Cell TumorOvarian Endometrioid Adenocarcinoma+1 more HonorHealth Research Institute
Testing effectiveness (Phase 2)WithdrawnNCT03836157What this trial is testingMirvetuximab Soravtansine (IMGN853) and Bevacizumab in Patients With Endometrial CancerWho this might be right forEndometrial CancerEndometrial AdenocarcinomaEndometrial Serous Adenocarcinoma+1 more University of Oklahoma
Large-scale testing (Phase 3)Study completedNCT00006011What this trial is testingComparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial CancerWho this might be right forEndometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Clear Cell Adenocarcinoma+3 more Gynecologic Oncology Group 659
Testing effectiveness (Phase 2)Active Not RecruitingNCT04152499What this trial is testingPhase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)Who this might be right forEpithelial Ovarian CancerGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma+7 more Klus Pharma Inc. 1,410
Testing effectiveness (Phase 2)Study completedNCT02093598What this trial is testingPOEM STUDY: A Phase IIa Trial in Endometrial Carcinoma With TemsirolimusWho this might be right forCarcinoma, EndometrioidmTOR Protein MedSIR 10
Early research (Phase 1)Active Not RecruitingNCT05858736What this trial is testingSafety, PK and Efficacy of AI-061 in Advanced Solid TumorsWho this might be right forMelanomaNon Small Cell Lung CancerHead and Neck Squamous Cell Carcinoma+14 more OncoC4, Inc. 18
Not applicableWithdrawnNCT05390021What this trial is testingPET/MRI in Endometrial CancerWho this might be right forCytoreductive SurgeryGrade 3 Endometrial Endometrioid AdenocarcinomaHigh Grade Serous Carcinoma+2 more Massachusetts General Hospital
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07349641What this trial is testingWeight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial CancerWho this might be right forEndometrial Atypical Hyperplasia/Endometrioid Intraepithelial NeoplasiaFIGO Grade 1 Endometrial Endometrioid Adenocarcinoma National Cancer Institute (NCI) 55
Early research (Phase 1)Looking for participantsNCT05238922What this trial is testingStudy of INCB123667 in Subjects With Advanced Solid TumorsWho this might be right forSolid Tumors Incyte Corporation 604
Testing effectiveness (Phase 2)Active Not RecruitingNCT06638931What this trial is testingAgnostic Therapy in Rare Solid TumorsWho this might be right forUrachal CancerParathyroid CarcinomaFibrolamellar Carcinoma+38 more Instituto do Cancer do Estado de São Paulo 28
Not applicableNot Yet RecruitingNCT06861855What this trial is testingPrognosis of METTL-14 in Endometrial CarcinomaWho this might be right forEndometrial CancerEndometrial Adenocarcinoma Assiut University 50
Early research (Phase 1)WithdrawnNCT04602117What this trial is testingISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic CancerWho this might be right forHER2-positive Breast CancerHER2 LowSYD-985+24 more QuantumLeap Healthcare Collaborative
Testing effectiveness (Phase 2)Looking for participantsNCT06330064What this trial is testingEvaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)Who this might be right forRecurrent or Metastatic Solid Tumors Daiichi Sankyo 520